Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zimmermann

Showing results (551-560 of 562) with videos related to

Pageof 57
Sort By:
ESMO Open|January 21, 2020
Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapyEdward B Garon, Giorgio Vittorio Scagliotti, Oliver Gautschi, et al.
Nature Cardiovascular Research|September 24, 2024
Evolution of translational control and the emergence of genes and open reading frames in human and non-human primate heartsJorge Ruiz-Orera, Duncan C Miller, Johannes Greiner, et al.
Stem Cells (Dayton, Ohio)|November 1, 2017
Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational ModelingOscar J Abilez, Evangeline Tzatzalos, Huaxiao Yang, et al.
Cardiovascular Research|September 7, 2023
Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy developmentFitzwilliam Seibertz, Tony Rubio, Robin Springer, et al.
Science Translational Medicine|November 3, 2021
Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to <i>TTN</i> mutationsAndrey Fomin, Anna Gärtner, Lukas Cyganek, et al.
Science Translational Medicine|October 8, 2020
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxideVirginie Montiel, Ramona Bella, Lauriane Y M Michel, et al.
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
Lancet (London, England)|September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
CJC Open|May 17, 2021
The COVID-19 Pandemic and Coronary Angiography for ST-Elevation Myocardial Infarction, Use of Mechanical Support, and Mechanical Complications in Canada: A Canadian Association of Interventional Cardiology National SurveyStéphane Rinfret, Israth Jahan, Kevin McKenzie, et al.
The Lancet. Oncology|November 23, 2019
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Pageof 57

Showing results (551-560 of 562) with videos related to

Sort By:
Pageof 57
ESMO Open|January 21, 2020
Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapyEdward B Garon, Giorgio Vittorio Scagliotti, Oliver Gautschi, et al.
Nature Cardiovascular Research|September 24, 2024
Evolution of translational control and the emergence of genes and open reading frames in human and non-human primate heartsJorge Ruiz-Orera, Duncan C Miller, Johannes Greiner, et al.
Stem Cells (Dayton, Ohio)|November 1, 2017
Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational ModelingOscar J Abilez, Evangeline Tzatzalos, Huaxiao Yang, et al.
Cardiovascular Research|September 7, 2023
Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy developmentFitzwilliam Seibertz, Tony Rubio, Robin Springer, et al.
Science Translational Medicine|November 3, 2021
Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to <i>TTN</i> mutationsAndrey Fomin, Anna Gärtner, Lukas Cyganek, et al.
Science Translational Medicine|October 8, 2020
Inhibition of aquaporin-1 prevents myocardial remodeling by blocking the transmembrane transport of hydrogen peroxideVirginie Montiel, Ramona Bella, Lauriane Y M Michel, et al.
European Heart Journal|October 9, 2018
Treatments targeting inotropyChristoph Maack, Thomas Eschenhagen, Nazha Hamdani, et al.
Lancet (London, England)|September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
CJC Open|May 17, 2021
The COVID-19 Pandemic and Coronary Angiography for ST-Elevation Myocardial Infarction, Use of Mechanical Support, and Mechanical Complications in Canada: A Canadian Association of Interventional Cardiology National SurveyStéphane Rinfret, Israth Jahan, Kevin McKenzie, et al.
The Lancet. Oncology|November 23, 2019
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trialDaniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Pageof 57